Clinical practice. Screening for colorectal cancer.

A healthy 76-year-old woman presents as a new patient for primary care. She reports having one daily bowel movement and no rectal bleeding. She has no family history of colorectal cancer. She reports having negative stool card tests during gynecologic examinations, most recently at 65 years of age. Would you advise this patient to undergo colon-cancer screening, and if so, what test would you recommend?

[1]  Eugene J Lengerich,et al.  American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2009, The American Journal of Gastroenterology.

[2]  D. Lieberman,et al.  Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. , 2008, Gastroenterology.

[3]  R. Chlebowski,et al.  Estrogen plus progestin and colorectal cancer in postmenopausal women. , 2004, The New England journal of medicine.

[4]  D. Lieberman,et al.  Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. , 2000, The New England journal of medicine.

[5]  Rinku Sutradhar,et al.  Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. , 2008, Gastroenterology.

[6]  Walter Park,et al.  Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. , 2008, JAMA.

[7]  K. Machens,et al.  Estrogen plus progestin and colorectal cancer in postmenopausal women. , 2004, The New England journal of medicine.

[8]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[9]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[10]  J. Stockman.  Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia , 2010 .

[11]  D. Ransohoff,et al.  Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.

[12]  E. Hawk,et al.  Colorectal cancer chemoprevention--an overview of the science. , 2004, Gastroenterology.

[13]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[14]  G. Spinzi,et al.  A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. , 2001, Gastrointestinal endoscopy.

[15]  G. Friedman,et al.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. , 1992, The New England journal of medicine.

[16]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[17]  Rongwei Fu,et al.  Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[18]  D. Lieberman,et al.  Procedural success and complications of large-scale screening colonoscopy. , 2002, Gastrointestinal endoscopy.

[19]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[20]  H. Brenner,et al.  Immunochemical Fecal Occult Blood Tests , 2009, Annals of Internal Medicine.

[21]  J. Yee,et al.  Accuracy of ct colonography for detection of large adenomas and cancers , 2009 .

[22]  E. Paulson,et al.  Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison , 2005, The Lancet.

[23]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[24]  H. Pohl,et al.  Prevalence of clinically important histology in small adenomas. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  J. Stockman,et al.  Complications of Colonoscopy in an Integrated Health Care Delivery System , 2008 .

[26]  D. Moher,et al.  Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force , 2007, Annals of Internal Medicine.

[27]  A. Zauber,et al.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .

[28]  Fred S. Drennan,et al.  Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. , 2006, JAMA.

[29]  S. Markowitz,et al.  Improved fecal DNA test for colorectal cancer screening. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[30]  D. Ransohoff,et al.  Adverse Events After Outpatient Colonoscopy in the Medicare Population , 2009, Annals of Internal Medicine.

[31]  Perry J Pickhardt,et al.  Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.

[32]  A. Schatzkin,et al.  Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia , 2005 .

[33]  J. P. Tucker,et al.  Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. , 2007, Journal of the National Cancer Institute.

[34]  A. Sonnenberg,et al.  Prevention of Colorectal Cancer by Flexible Endoscopy and Polypectomy: A Case-Control Study of 32 702 Veterans , 1995, Annals of Internal Medicine.

[35]  J. Burdick,et al.  Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. , 2004, JAMA.

[36]  Harminder Singh,et al.  Colonoscopy and its complications across a Canadian regional health authority. , 2009, Gastrointestinal endoscopy.

[37]  S. Woolf,et al.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. , 2003, Gastroenterology.

[38]  J. Schulman,et al.  Complications of Colonoscopy in an Integrated Health Care Delivery System , 2006, Annals of Internal Medicine.

[39]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[40]  L. Rabeneck,et al.  Association of Colonoscopy and Death From Colorectal Cancer , 2009, Annals of Internal Medicine.

[41]  T. Church,et al.  The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.

[42]  D. Ransohoff,et al.  Five-Year risk of colorectal neoplasia after negative screening colonoscopy , 2008, Acta Endoscopica.

[43]  Dawn Provenzale,et al.  Five-year colon surveillance after screening colonoscopy. , 2007, Gastroenterology.

[44]  J. Reguła,et al.  Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. , 2006, The New England journal of medicine.

[45]  R. Pearson.  Association of Colonoscopy and Death from Colorectal Cancer , 2009 .

[46]  Gurkirpal Singh,et al.  Risk of perforation from a colonoscopy in adults: a large population-based study. , 2009, Gastrointestinal endoscopy.

[47]  M. Bretthauer,et al.  Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial , 2009, BMJ : British Medical Journal.

[48]  D. Lieberman,et al.  Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice , 2005, Annals of Internal Medicine.

[49]  H. Brenner,et al.  Comparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma Detection , 2009, Annals of Internal Medicine.

[50]  S. Rathgaber,et al.  Colonoscopy completion and complication rates in a community gastroenterology practice. , 2005, Gastrointestinal endoscopy.

[51]  P. Pickhardt,et al.  Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. , 2003, The New England journal of medicine.

[52]  Dale Kraemer,et al.  Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[53]  D. Ransohoff,et al.  A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood , 2005, Annals of Internal Medicine.

[54]  D. Lieberman,et al.  Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. , 2008, JAMA.

[55]  D. Plattner.  Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults , 2004, European Surgery.

[56]  D. Ransohoff,et al.  Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. , 2000, The New England journal of medicine.

[57]  Harminder Singh,et al.  Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. , 2006, JAMA.

[58]  Robert Fletcher,et al.  Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. , 2007, Gastrointestinal endoscopy.

[59]  B. Overholt,et al.  Perforation during colonoscopy in endoscopic ambulatory surgical centers. , 2003, Gastrointestinal endoscopy.

[60]  E T Stewart,et al.  A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. , 2000, The New England journal of medicine.

[61]  A. Neugut,et al.  Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. , 2003, Journal of the National Cancer Institute.